Stock DNA
Pharmaceuticals & Biotechnology
INR 431 Cr (Micro Cap)
NA (Loss Making)
34
0.67%
-0.62
-3.83%
1.08
Total Returns (Price + Dividend) 
Latest dividend: 5 per share ex-dividend date: Jul-25-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Albert David Stock Falls to 52-Week Low of Rs.738.95 Amidst Prolonged Downtrend
Albert David, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.738.95 today, marking a significant milestone in its ongoing price decline. This level reflects a continuation of the stock’s subdued performance over the past year, contrasting sharply with broader market trends.
Read More
Albert David Sees Revision in Market Evaluation Amid Challenging Financial Trends
Albert David, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights shifts across key analytical parameters, signalling caution for investors amid subdued returns and operational pressures.
Read More
Albert David Stock Falls to 52-Week Low of Rs.740.25 Amidst Continued Downtrend
Albert David's shares reached a fresh 52-week low of Rs.740.25 today, marking a significant decline amid a sustained downward trend over recent sessions. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology industry.
Read More Announcements 
Closure of Trading Window
22-Dec-2025 | Source : BSEClosure of Trading Window from 1st January 2026 for declaration of Unaudited Financial Results for the third quarter and nine months period ended 31st December 2025
Closure of Trading Window
22-Dec-2025 | Source : BSEClosure of Trading window from 1st January 2026 for declaration of Unaudited Financial Results for the third quarter and nine months period ended 31st December 2025
Announcement under Regulation 30 (LODR)-Resignation of Director
19-Dec-2025 | Source : BSEResignation of Mr. Umesh Manohar Kunte as Director w.e.f 18-12-2025.
Corporate Actions 
No Upcoming Board Meetings
Albert David Ltd has declared 50% dividend, ex-date: 25 Jul 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 4 FIIs (0.6%)
Kothari Investment And Industries Private Limited (41.36%)
General Insurance Corporation Of India (1.61%)
27.72%
Quarterly Results Snapshot (Standalone) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is -11.38% vs 5.64% in Sep 2024
YoY Growth in quarter ended Sep 2025 is -118.26% vs -10.99% in Sep 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -15.96% vs 1.44% in Sep 2024
Growth in half year ended Sep 2025 is -87.43% vs -15.69% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -0.93% vs 5.09% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -55.96% vs 92.69% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -4.60% vs 6.12% in Mar 2024
YoY Growth in year ended Mar 2025 is -77.19% vs 108.52% in Mar 2024






